CJC-1295

CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) that is studied for its ability to stimulate the body's natural release of growth hormone over an extended period. Ipamorelin is a selective growth hormone secretagogue that acts through a different receptor pathway, making it a complementary research peptide when paired with CJC-1295.

Researchers often study this combination because the peptides activate separate signaling mechanisms involved in growth hormone regulation. Current research has explored their potential roles in muscle physiology, recovery, metabolic function, sleep quality, body composition, and healthy aging. While these areas continue to be investigated, well-controlled human clinical evidence remains limited.

For Research Use Only. This product is intended exclusively for laboratory and scientific research. It is not approved by the U.S. Food and Drug Administration for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease.